Both in Pharmaceuticals
Eli Lilly & vs Abbott Laboratories
Over the past year LLY returned +63.1% and ABT returned −24.1%; their daily moves had a correlation of 0.19.
LLY +63.1% ABT −24.1%Growth of $1, one year, split-adjusted
| Metric | LLY | ABT |
|---|---|---|
| Price | $1,184.78 | $100.98 |
| Market cap | $1.06T | $174.73B |
| Today | +0.11% | −0.31% |
| 1 month | +0.7% | −9.5% |
| 6 months | +34.9% | −2.9% |
| Year to date | +10.2% | −19.4% |
| 1 year | +65.8% | −24.3% |
| Revenue growth (YoY) | +47.7% | +13.0% |
| Gross margin | 85.8% | 57.7% |
| Net margin | 30.9% | 7.4% |
| P/E (TTM) | 39.5× | 32.2× |
| Price / sales | 13.3× | 3.8× |
| Net cash | -$45.96B | -$27.00B |
| Dividend yield | 0.58% | 2.50% |
| Volatility (60d) | 29.7% | 29.9% |
| Short % of float | 0.9% | 1.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).